Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Evans, S. E.
Right arrow Articles by Limper, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Evans, S. E.
Right arrow Articles by Limper, A. H.
(Chest. 2004;125:1063-1070.)
© 2004 American College of Chest Physicians

Transforming Growth Factor-ß1 and Extracellular Matrix-Associated Fibronectin Expression in Pulmonary Lymphangioleiomyomatosis*

Scott E. Evans, MD; Thomas V. Colby, MD, FCCP; Jay H. Ryu, MD, FCCP and Andrew H. Limper, MD, FCCP

* From the Thoracic Diseases Research Unit (Drs. Evans, Ryu, and Limper), Division of Pulmonary & Critical Care, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN; and the Department of Laboratory Medicine and Pathology (Dr. Colby), Mayo Clinic, Scottsdale, AZ.

Correspondence to: Andrew H. Limper, MD, FCCP, 8-24 Stabile Building, Mayo Clinic, Rochester, MN, 55905; e-mail limper.andrew@mayo.edu

Study objectives: Lymphangioleiomyomatosis (LAM) is a rare disorder of unknown etiology, affecting almost exclusively women of childbearing age, that is associated with the proliferation of spindle cells and cystic changes in the affected lung. The underlying processes that contribute to this disease are poorly understood. Transforming growth factor (TGF)-ß1 is a potent cytokine that promotes mesenchymal cell proliferation and regulates the synthesis of extracellular matrix (ECM) components, particularly fibronectins. Herein, we evaluate the expression of TGFß1 and matrix-associated fibronectin in lung specimens demonstrating LAM.

Design: Lung biopsy specimens that were confirmed to contain pathologic LAM cells were obtained from 13 patients. The specimens were submitted to immunohistochemical evaluation for TGFß1 and fibronectin, as well as the typical markers of LAM cells. Healthy lung parenchyma surrounding resected neoplasms was studied in a parallel fashion as control tissues.

Measurements and results: In all 13 LAM cases and in healthy lung parenchyma, we demonstrated that TGFß1 localized consistently to airway epithelial cells. However, in LAM tissues, matrix-associated TGFß1 was also consistently found in regions containing pathologic LAM cells. Notably, more abundant TGFß1 was observed in highly cellular areas compared to the walls of chronic cystic regions in LAM tissues. Fibronectin, a matrix component that is strongly expressed in response to active TGFß1 was found to consistently colocalize with this protein in these highly cellular regions, supporting TGFß1 activity in these regions. The markers of proliferating LAM cells, including proliferating cell nuclear antigen, were also markedly present in these highly cellular LAM regions.

Conclusion: These studies suggest that the proliferation of aberrant LAM cells may be associated with altered regional expression of TGFß1 and related ECM proteins.

Key Words: fibronectins • lymphangioleiomyomatosis • transforming growth factor-ß




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
B. Camoretti-Mercado, D. J. Fernandes, S. Dewundara, J. Churchill, L. Ma, P. C. Kogut, J. F. McConville, M. S. Parmacek, and J. Solway
Inhibition of Transforming Growth Factor beta-enhanced Serum Response Factor-dependent Transcription by SMAD7
J. Biol. Chem., July 21, 2006; 281(29): 20383 - 20392.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J. L. Black, Q. Ge, S. Boustany, P. R. A. Johnson, M. H. Poniris, A. R. Glanville, B. G. G. Oliver, L. M. Moir, and J. K. Burgess
In vitro studies of lymphangioleiomyomatosis
Eur. Respir. J., October 1, 2005; 26(4): 569 - 576.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Chest Physicians.